Browse Subject Areas

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Pedilanthus tithymaloides Inhibits HSV Infection by Modulating NF-κB Signaling

  • Durbadal Ojha,

    Affiliation ICMR Virus Unit, ID and BG Hospital, General Block 4, 57 Dr Suresh Chandra Banerjee Road, Beliaghata, Kolkata 700010, India

  • Rashmi Das,

    Affiliation ICMR Virus Unit, ID and BG Hospital, General Block 4, 57 Dr Suresh Chandra Banerjee Road, Beliaghata, Kolkata 700010, India

  • Parveen Sobia,

    Affiliation Department of Microbiology, College of Cell Sciences, University of KwaZulu-Natal, Durban 4001, South Africa

  • Vedprakash Dwivedi,

    Affiliation Department of Microbiology, College of Cell Sciences, University of KwaZulu-Natal, Durban 4001, South Africa

  • Soma Ghosh,

    Affiliations ICMR Virus Unit, ID and BG Hospital, General Block 4, 57 Dr Suresh Chandra Banerjee Road, Beliaghata, Kolkata 700010, India, Department of Pharmaceutical Technology, Jadavpur University, Raja SC Mallick Road, Kolkata 700032, India

  • Amalesh Samanta,

    Affiliation Department of Pharmaceutical Technology, Jadavpur University, Raja SC Mallick Road, Kolkata 700032, India

  • Debprasad Chattopadhyay

    Affiliation ICMR Virus Unit, ID and BG Hospital, General Block 4, 57 Dr Suresh Chandra Banerjee Road, Beliaghata, Kolkata 700010, India

Pedilanthus tithymaloides Inhibits HSV Infection by Modulating NF-κB Signaling

  • Durbadal Ojha, 
  • Rashmi Das, 
  • Parveen Sobia, 
  • Vedprakash Dwivedi, 
  • Soma Ghosh, 
  • Amalesh Samanta, 
  • Debprasad Chattopadhyay


Pedilanthus tithymaloides (PT), a widely used ethnomedicinal plant, has been employed to treat a number of skin conditions. To extend its utility and to fully exploit its medicinal potential, we have evaluated the in vitro antiviral activity of a methanolic extract of PT leaves and its isolated compounds against Herpes Simplex Virus type 2 (HSV-2). Bioactivity-guided studies revealed that the extract and one of its constituents, luteolin, had potent antiviral activity against wild-type and clinical isolates of HSV-2 (EC50 48.5–52.6 and 22.4–27.5 μg/ml, respectively), with nearly complete inhibition at 86.5–101.8 and 40.2–49.6 μg/ml, respectively. The inhibitory effect was significant (p<0.001) when the drug was added 2 h prior to infection, and was effective up to 4 h post-infection. As viral replication requires NF-κB activation, we examined whether the observed extract-induced inhibition of HSV-2 was related to NF-κB inhibition. Interestingly, we observed that treatment of HSV-2-infected cells with extract or luteolin suppressed NF-κB activation. Although NF-κB, JNK and MAPK activation was compromised during HSV replication, neither the extract nor luteolin affected HSV-2-induced JNK1/2 and MAPK activation. Moreover, the PT leaf extract and luteolin potently down-regulated the expression of tumor necrosis factor (TNF)-α, Interleukin (IL)-1β, IL-6, NO and iNOS and the production of gamma interferon (IFN-γ), which are directly involved in controlling the NF-κB signaling pathway. Thus, our results indicate that both PT leaf extract and luteolin modulate the NF-κB signaling pathway, resulting in the inhibition of HSV-2 replication.


Diseases caused by Herpes Simplex Virus (HSV), includes mild cold sores, keratoconjunctivitis, genital herpes, and life-threatening encephalitis, affect more than one-third of the global population. Following its entry through bruised skin or mucosal surfaces, HSV primarily infects epithelial cells and is finally transported to the nerve ganglia for life-long latency with periodic reactivation [1]. After entry, HSV triggers innate immune responses that eventually lead to antigen-specific adaptive immune responses, but the virus is able to overcome these responses to establish latent infection. HSV infection is known to require enhanced activation of NF-κB [24] and MAPK in targeted epithelial and nerve cells [59], and compound(s) that block these pathways can inhibit HSV infection. Resveratrol, a natural stilbenoid, and curcumin, a diarylheptanoid, were reported to inhibit HSV infection through NF-κB inhibition [10, 11]. NF-κB, MAPKs and JNK transcriptionally control the production of most cytokines and chemokines [5, 12, 13].

Pedilanthus tithymaloides L. Poit. (Euphorbiaceae) or devil's-backbone is a low tropical shrub, locally known as Rang-chita. Different parts of the plant are used in traditional Indian medicine as abortive, anticancer, anti-inflammatory and antimicrobial [1416], with therapeutic activity against skin disorders [17]. We previously isolated the flavonoid luteolin along with the new compound tetradecanediol sodium salt from the methanolic extract (ME) of PT leaves [15]. Luteolin has been reported to suppress NF-κB activation and COX-2 expression triggered by the MyD88-independent pathway via Toll-like receptor-4 [18]. It has also been reported that luteolin inhibits the post-attachment stage of Enterovirus 71 and Coxsackie virus A16 [19], replication of Poliovirus [20], Influenza virus A [21], and HIV-1 [22]. Further, crude extracts from Avicenna marina inhibit HSV plaque formation [23], wheras Houttuynia cordata extracts inhibit HSV infection through inhibition of NF-κB activation [24]. Furthermore, treatment with 7,3'-disulfate luteolin or luteolin from Zostera marina induced increased survival of mice infected with the tick-borne encephalitis [25]. However, in depth studies on the antiviral activity and mechanisms of action, including the regulatory mechanism of PT leaves against HSV-2 have not yet been reported. Following ethnomedicinal use, we evaluated the in vitro anti-HSV-2 activity of ME from PT leaves (MEPT) and its isolated compound(s) in a bioactivity-guided study, and investigated their possible mechanisms of action. We observed that MEPT and luteolin exhibited potent anti-HSV-2 activity, blocked HSV-2 infection through the inhibition of NF-κB activation, but had no effect on virus-induced JNK and MAPK activation.

Material and Methods


RPMI 1640, penicillin and streptomycin were from Sigma Chemical Co. (St Louis, MO, USA); Dulbecco modified Eagle medium (DMEM) and fetal calf serum (FCS) were from Gibco BRL (Grand Island, NY, USA). ELISA antibody kits (IL-1α, IL-6, IFN-γ and TNF-α) were purchased from BD Biosciences (San Diego, CA); while Santa Cruz Biotechnology (Santa Cruz, CA) and Abcam® (Cambridge, MA, USA) supplied antibodies against IκB-α, NF-κB/p65, MAPK/p38, p-p38, JKN1/2, p-JNK1/2 and GAPDH. Tissue culture reagents were purchased from Gibco Laboratories, USA; and primers for semi-quantitative PCR were from IDT, California, USA. Other chemicals were purchased from Sigma (USA) or Merck (Germany).


The PT leaves was collected from the Begumpur village of Baruipur Block, 24-Parganas (S), West Bengal and were identified by a taxonomist at the Indian Botanic Garden, Botanical Survey of India, Howrah, India. The voucher specimen (CNH/1-1(56)/2006/Tech-11/1450) has been deposited at the host institute.

Extraction and bioactivity-guided isolation

The extraction protocols were similar as described earlier [14, 15], and the bioactivity-guided isolation has been described in S1 File.

Cells and viruses

Vero cells (ATCC, USA) were cultured in DMEM and RPMI-1640, respectively, with 5% FCS, penicillin (100 U/mL) and streptomycin (100 μg/ml) at 37°C in 5% CO2. The viral strains include HSV-2G (ATCC734), two clinical isolates (ICMR/VU-2012-17, 20) and a TK-deficient HSV-2 isolate (ICMR/VU-2013-7) provided by Professor P.K. Dutta, Department of Dermatology, Calcutta Medical College & Hospital, Kolkata. All virus strains were passaged in Vero cells.

Preparation of mouse peritoneal macrophages

The animals used were female and male BALB/c mice (18–20 gm), acclimatized for 15 days in the Animal House facility, with standard food and water ad libitum. The animal experiments were conducted in accordance with the OECD guidelines, and as approved by the Institutional Animal Care and Use Committee (IACUC) of Jadavpur University, Kolkata (Approval No: 0367/01/C/CPCSEA). Seven-week-old mice were intraperitoneally injected with 1 ml of 4% thioglycolate. After 5 days the animals were subjected to Ketamine hydrochloride (100 mg/kg i.m.) anesthesia to minimize suffering, and euthanized by cervical dislocation. The peritoneal cells were harvested by ice-cold PBS, and centrifuged at 1200 rpm in 4°C for 5 min. The cell pellet was suspended in RPMI-1640 supplemented with 10% FCS, and the cells were counted on Neubaur’s chamber. The cells were cultured for 6 h at 37°C in 5% CO2, washed with PBS to remove the non-adherent cells, and further incubated for 24 h [26].

Cytotoxicity and antiviral assay

The Vero cells treated with serially diluted MEPT, isolated compounds luteolin and tetradecanediol, were incubated at 37°C in 5% CO2, using acyclovir (ACV) and DMSO (0.1%) as controls. After 72h, MTT assay was carried out using commercial kit, following the manufacturer’s protocol (MTT; Sigma) and absorbance was read at 570 nm. The 50% cytotoxic concentration (CC50) was calculated by linear regression of the dose-dependent curves while antiviral activity was measured by plaque reduction assay (PRA). Briefly, Vero cells infected with clinical isolates (VU/12-17, VU/2012/20 and VU/2013-7) or wild-type HSV-2G (100 PFU) were treated with serial dilutions of test drugs and then overlaid with 1% methylcellulose. The plaques were counted after 72 h to calculate the virus titers by scoring the plaque-forming units (PFU). The effective concentration of test drugs that reduced plaque numbers by 50% (EC50) was interpolated from the dose-response curves [27, 28].

Time-of-addition assay

The effect of drug addition over time was carried out to determine the possible step(s) of viral life cycle targeted by MEPT or luteolin. Following three different approaches Vero cells were exposed to MEPT (86.5 μg/ml) or luteolin (40.2 μg/ml) before, during or after infection with HSV-2 (100 PFU). For pre-infection, cells were treated with MEPT or luteolin for 2 h, washed with PBS and then infected with HSV-2. In case of co-infection the cells were simultaneously exposed to HSV-2 and MEPT or luteolin, and after 1 h the virus-drug mixture was removed to conduct PRA of the treated cells. For post-infection (p.i) studies the cells were first infected with HSV-2 for 1 h, washed with PBS, and then treated with MEPT or luteolin at intervals of 4, 8, 12 and 24 h, and finally the cells were harvested after 24 h for PRA [28].

Western blot analysis

The HSV-2G (10 m.o.i.) infected Vero cells were treated with MEPT (86.5 μg/ml) or luteolin (40.2 μg/ml) and after 4 h, equal amounts of protein (40 μg/sample) extract from whole cells were harvested in buffer (200 μl/well) containing 50nM Tris-Cl, 150mM NaCl, 1% NP-40, 1% Triton X-100, and 1% protease inhibitor cocktail. The soluble fraction was then separated by centrifugation (16000 g for 10 min) at 4°C, subjected to SDS-PAGE and blotted to pre-equilibrated PVDF membrane (Thermo Scientific, USA). The membrane was then blocked in 5% NFDM in 1X TBST (20 mM Tris, pH 7.5, 150 mM NaCl, 0.5% Tween 20), rinsed and incubated with specific antibody in 5% BSA at 4°C overnight. Immunoblotting was performed with peroxidase-labelled specific antibodies and visualized by ECL Western blot detection kit (Millipore, USA) [29, 30].

Isolation of RNA and Semi-quantitative RT- PCR

RNA was isolated from the HSV-2G (5 m.o.i.) infected, MEPT (86.5 μg/ml) or luteolin (40.2 μg/ml) treated (12h p.i.) Vero cell/macrophages using RNeasy Mini kit (Qiagen, Germany). The total RNA in RNase-free water was mixed in 20 μl of RT mix (containing 5X VILO Reaction Mix, 10X SuperScript Enzyme Mix and DEPC treated water) and subjected to cDNA synthesis using the GeneAmp PCR System 9600 (Bio-Rad MJ Mini, Hercules, CA, USA). The cDNA (10%) was subjected to standard PCR amplification using the primers for iNOS genes, using gapdh as internal standard. The sequences of the forward and reverse primer are listed in Table 1. The respective DNA and proteins bands were analysed using a model GS-700 Imaging Densitometer and Molecular Analyst software (version 1.5; Bio-Rad Laboratories, CA, USA).

Measurement of Nitric Oxide and Cytokine release

Macrophages cultured in 24 well plates (1 × 106 cells/well) were treated with HSV-2 (5 m.o.i.), and incubated for 1h. The activated cells were then treated with MEPT (100 μg/ml) or luteolin (20 μg/ml) for 24 h. The concentrations of NO and cytokines in the supernatant were determined by Griess reagent (Sigma, USA) [31] and by sandwich ELISA [26, 31], respectively.

Statistical analysis

Results were expressed as SEM (n = 6) and the statistical analyses were performed with one-way analysis of variance (ANOVA), followed by Dunnett’s test. A value of p < 0.05 was considered to be statistically significant, compared with the respective control.


Isolation and identification of anti-HSV compounds

The MEPT was partitioned between n-Butanol and water, and saturated with n-Butanol. The n-Butanol fraction separately chromatographed over a silica gel column resulted in the isolation of a flavone as compound-1 (Fig 1A), identified as 2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-chromen-4-one or luteolin [14]; and a new tetradecanediol, sodium salt as compound-2 (Fig 1B), confirmed by comparing data in the literature [32].

Fig 1. Chemical structure of the isolated compound(s) Luteolin (A) and Tetradecanediol (B) isolated from the antiviral fraction of Pedilanthus tithymaloides leave extracts.

Inhibition of HSV-1 infection

The antiviral activity of MEPT leaves, isolated luteolin and tetradecanediol was determined against HSV-2G, two clinical isolates, and one TK-deficient stain of HSV-2 (100 PFU) using PRA in the presence of acyclovir and DMSO (0.1%) as control. The results showed a dose-dependent inhibition of viral plaque formation by both MEPT leaves and luteolin (data not shown) but tetradecanediol had no anti-HSV activity (Table A in S1 File). While the PRA demonstrated that MEPT leaves at 48.5–52.6 μg/ml and luteolin at 22.4–27.5 μg/ml inhibited all the strains tested, which was far below their CC50 concentration (Table 2). Further, nearly complete (EC99) inhibition of viral growth was achieved at 86.5 μg/ml of MEPT leaves or 40.2 μg/ml of luteolin against HSV-2G.

Table 2. Assessment of cytotoxicity and ant-HSV activity of MEPT leaves and Luteolin.

Effect of luteolin treatment at different times prior or after infection

To identify the possible phase of viral infection imparted by MEPT leaves or luteolin, we performed time-of-addition assay. The results revealed that the inhibitory effect was significant when MEPT leaves or luteolin were added 2 h prior, during or 4h p.i., which correlates with the entry and early stages of virus infection (Fig 2).

Fig 2. Inhibitory effect of MEPT leaves or isolated Luteolin in time-of-addition assays.

Inhibitory effect of MEPT leaves, Luteolin or ACV (F) at various time points: pre-infection (-2 h), co-infection (0 h) and post-infection (1–12 h) with HSV-2G (100 PFU/well), determined by a plaque reduction assay. Each bar represents the mean ± S.E.M of three independent experiments (*, P<0.001, compare with control).

Effects of MEPT leaves or luteolin on HSV-2-induces NF-κB, MAPK, JNK1/2 and IκBα activation

As efficient HSV-2 replication requires NF-κB activation [3], and HSV-infection selectively promotes MAPK phosphorylation [5, 33], we examined whether MEPT leaves or luteolin block NF-κB, MAPK and JNK1/2 pathways during infection. HSV-2 infected cells, untreated or treated with MEPT leaves (86.5 μg/ml) or luteolin (40.2 μg/ml) for 4 h, were used to determine NF-κB nuclear translocation by immunoblotting. In uninfected cells, p65 was detected at relatively low levels, whereas, in HSV-2-infected cells p65 activation was significantly induced at 24 h p.i. MEPT leaves or luteolin treatment abated HSV-2-induced p65 nuclear translocation, suggesting that MEPT and luteolin blocked HSV-2-induced NF-κB activation, but not MAPK phosphorylation (Fig 3). As shown in Fig 4, MEPT or luteolin treatment significantly blocked viral ICP0 and ICP27 expression, implying inhibition of HSV-2 replication. Inhibition of IκB-α degradation induced following HSV-2 infection, was also detected in these samples. Together, our data suggest that MEPT/luteolin block HSV-2 infection through NF-κB inhibition.

Fig 3. Effect of MEPT leaves and Luteolin on HSV-2-induced MAPK, JNK1/2, NF-kB and IkBα activation.

Expression of MAPK (A), JNK (B), NF-kB (C) and IkBα (D) was determined by Western blot, using GAPDH as the internal control. The HSV-2-infected peritoneal macrophage(s) were treated with MEPT (86.5 μg/ml) or Luteolin (40.2 μg/ml) and after 4 h, equal amounts of protein (40 μg/sample) extract from whole cells were harvested in buffer (200 μl/well) containing 50 nM Tris-Cl, 150 mM NaCl, 1% NP-40, 1% Triton X-100, and 1% protease inhibitor cocktail. The soluble fraction was separated by centrifugation, subjected to SDS-PAGE and blotted to pre-equilibrated PVDF membrane. The membrane was then blocked in 5% NFDM in 1X TBST, rinsed and incubated with specific antibody at 4°C overnight. Immunoblotting was performed with peroxidase-labelled specific antibodies and visualized by ECL Western blot detection kit. The average expression of NF-kB was significantly higher in the HSV-2-induced macrophage, as compared to the control and MEPT or luteolin co-treated group (*, P<0.05; **, P<0.001). Lane 1, cells only control; Lane 2, cells + HSV-2; Lane 3, cells + HSV-2 + MEPT leaves; Lane 4, cells + HSV-2 + luteolin.

Fig 4. Effect of MEPT and Luteolin on HSV-2-induced ICP0 and DNA polymerase gene expression.

The HSV-2 infected Vero cells were treated with the MEPT leaves or Luteolin, incubated for 12 h, following which RNA was isolated and subjected to RT–PCR analysis for expression of ICP0 and DNA pol mRNA. Lane 1, cells only control; lane 2, cells +HSV-2; Lane 3, cells + HSV-2 + MEPT leaves; Lane 4, cells + HSV-2 + luteolin.

Luteolin reduces HSV-2-induced cytokine and NO production

Because NF-κB regulates the production of many inflammatory cytokines during HSV-infection [26], we examined HSV-2-induced cytokines, NO and iNOS gene expression in mouse peritoneal macrophages treated with MEPT leaves or luteolin (Fig 5). We observed a significant down-regulation of TNF-α, IL-1β, IL-6 and IFN-γ, compared with the infection control, by ELISA and qPCR (Fig 6). NO and iNOS expression were suppressed in MEPT- or luteolin-treated HSV-2 infected macrophage, compared with untreated cells.

Fig 5. Effect of MEPT leaves and Luteolin on NO production and iNOS expression in HSV-2 infected murine macrophages.

(A) Macrophages (106 cells/ml) were infected with HSV-2 treated with the MEPT leaves (100 μg/ml) or Luteolin (20 μg/ml), and incubated for 24 h. The supernatant was removed and the concentration of NO was determined by Griess reagent. Data are expressed as Mean ± SD from triplicate experiments, yielding similar results (m moles of nitrite). Asterisks indicate a statistically significant increase (*, P<0.05; **, P<0.001) in nitrite generation, compared to the infected macrophages. (B) HSV-2-infected macrophages were treated with the MEPT leaves or Luteolin, incubated for 12 h, following which RNA was isolated and subjected to RT–PCR analysis for the expression of iNOS2 mRNA. The data are expressed as Mean ± SD from triplicate experiments yielding similar results. The asterisk indicates a statistically significant increase (*, P<0.001) in iNOS2 expression, compared to the infected macrophage.

Fig 6. Effect of MEPT leaves and Luteolin on pro-inflammatory cytokine release in HSV-2-infected peritoneal macrophages.

Peritoneal macrophages were cultured overnight and infected with HSV-2, washed after 1 h and then treated with MEPT leaves (100 μg/ml) or Luteolin (20 μg/ml). The cells were further incubated for 24 h, and the cell-free supernatants were subjected to sandwich ELISA to determine the level of (A) TNF-α, (C) IL-1β, (E) IL-6 and (G) IFN-γ (pg/mL). The ELISA data are expressed as Mean ± SD from triplicate experiments, yielding similar results. Asterisks indicate statistically significant (*, P<0.05; **, P<0.001) induction of TNF-α, IL-1ß, IL-6, and IFN-γ release, compared to the infected macrophages.


Extracts from medicinal plants, particularly ethnomedicinal plants and their phytoconstituents, are reported to have anti-herpetic activity in cell cultures [34, 35]. The ethnomedicinal plant P. tithymaloides is used in Indian traditional medicine and has beneficial activities against skin ailments and microbial infections [14, 17]. To validate this use we have evaluated the antiviral activity of P. tithymaloides leaf extract and isolated compounds, along with their probable mode and mechanism of action against HSV-2.

HSV is one of the most common pathogenic viruses that inflicts a range of pathologies–from mild discomforts to lethal effects. Currently employed anti-herpetic drugs include the modified nucleotide analogue acyclovir and related prodrugs that inhibit viral thymidine kinase and/or DNA polymerase [36]. Although these drugs effectively reduce viral growth and multiplication, they fail to eliminate the virus from the infected individual, thereby increasing the risk of emergence of drug-resistant strains [37]. Therefore, new anti-HSV compounds, particularly non-nucleoside compounds and agents with different targets than the DNA polymerase are needed.

HSV infection is influenced by cellular signaling pathways and transcription factors, including activation of MRPK that promotes viral replication [38, 39]. Furthermore, HSV activates IκB kinase that triggers IκB-degradation in the early stage of infection resulting in a remarkable and unrelenting activation of NF-κB in epithelial, neuronal and lymphoid cells [4042]. Supporting previous reports that secondary metabolites of plants that can inhibit NF-κB or MAPK activation also inhibit HSV infection [23], we found that MEPT and luteolin can inhibit replication of the clinical isolates and TK-deficient strains of HSV-2, accompanied with NF-κB effects. On contrast with the previous reports that HSV-2 activates MAPK [5, 33], we found neither MEPT nor luteolin affects HSV-2-induced MAPK and JNK activation.

The transcriptional regulator NF-κB plays a vital role in cell proliferation and viral gene expression of a number of viruses. Its activation prevents apoptosis of the host cell, which is essential for viral replication. It has been shown that the A and J type cyclopentemone prostaglandins (cyPG) are required for blocking TNF-α-induced NF-κB activation, through direct inhibition and modification of the IKKβ subunit of IKK [40], an effect related to the potent antiviral activity of cyPG. Curcumin, an inhibitor of NF-κB activation [43], has also been shown to inhibit HSV immediate early gene expression and replication [11]. However, resveratrol, a natural stilbenoid, suppresses HSV-induced NF-κB activation, which results in reduced expression of HSV genes and viral DNA synthesis [10, 24]. These findings concur with our results and reveal that compounds targeting signaling pathways may exert selective activity against a varied group of viral pathogens [44, 45].

HSV infection elicits production of various chemokines and cytokines, including TNF-α, IL-1β, IL-6, RANTES, and IFN-γ [46, 47]. Here, we observed that HSV infection of peritoneal macrophage leads to significantly increased production of TNF-α, IL-1β, IFN-γ and increased expression of iNOS. In contrast, MEPT- or luteolin-treated groups of animals exhibited significantly down-regulated production of TNF-α, IL-1β, IL-6, IFN-γ and iNOS expression.


We have evaluated the in vitro antiviral activity of extracts of MEPT leaves and the isolated compound luteolin, as well as possible modes of action against HSV-2 and virus-induced inflammation. MEPT and luteolin exhibited strong antiviral activity (EC50) against all tested isolates of HSV-2 at 48.5–52.6 and 22.4–27.5 μg/m, respectively, far below their CC50 concentration (436.5 and 278.6 μg/ml); complete inhibition (EC99) of HSV-2 multiplication was achieved at 86.5 and 40.2 μg/ml, respectively, within 2–4 h post-infection. This was due to inhibition of NF-κB activation, but did not affect HSV-2-induced JNK and MAPK activation.

Supporting Information

S1 File. Extraction and isolation of luteolin and tetradecanediol, sodium salt from methanol extract of P. tithymaloides leaves.

Table A, Assessment of cytotoxicity and ant-HSV activity of Tetradecanediol.



We are thankful to the ICMR Virus Unit, Kolkata for laboratory facility and Dr NB Mondal, Emeritus Scientist, IICB, Kolkata for the isolation of the compound.

Author Contributions

Conceived and designed the experiments: DC DO. Performed the experiments: DO RD PS VPD SG. Analyzed the data: DC DO AS. Contributed reagents/materials/analysis tools: DC. Wrote the paper: DC DO.


  1. 1. Du T, Zhou G, Roizman B. Modulation of reactivation of latent herpes simplex virus 1 in ganglionic organ cultures by p300/CBP and STAT3. Proc Natl Acad Sci USA. 2013; 110(28): E2621–28. pmid:23788661
  2. 2. Yedowitz JC, Blaho JA. Herpes simplex virus 2 modulates apoptosis and stimulates NF-kappaB nuclear translocation during infection in human epithelial HEp-2 cells. Virology. 2005; 342: 297–310. pmid:16150474
  3. 3. Gregory D, Hargett D, Holmes D, Money E, Bachenheimer SL. Efficient replication by herpes simplex virus type 1 involves activation of the Ikappa B kinase-Ikappa B-p65 pathway. J Virol. 2004; 78: 13582–90. pmid:15564469
  4. 4. Patel A, Hanson J, McLean TI, Olgiate J, Hilton M, Miller WE, et al. Herpes simplex type 1 induction of persistent NF-kappaB nuclear translocation increases the efficiency of virus replication. Virology. 1998; 247: 212–22. pmid:9705914
  5. 5. Huang W, Hu K, Luo S, Zhang M, Li C, Jin W, et al. Herpes simplex virus type 2 infection of human epithelial cells induces CXCL9 expression and CD4+ T cell migration via activation of p38-CCAAT/enhancer-binding protein-β pathway. J Immunol. 2012; 188(12): 6247–57. pmid:22586042
  6. 6. Hargett D, McLean T, Bachenheimer SL. Herpes simplex virus ICP27 activation of stress kinases JNK and p38. J Virol. 2005; 79: 8348–60. pmid:15956580
  7. 7. Karaca G, Hargett D, McLean TI, Aguilar JS, Ghazal P, Wagner EK, et al. Inhibition of the stress-activated kinase, p38, does not affect the virus transcriptional program of herpes simplex virus type 1. Virology. 2004; 329: 142–56. pmid:15476882
  8. 8. Perkins D, Pereira EF, Gober M, Yarowsky PJ, Aurelian L. The herpes simplex virus type 2 R1 protein kinase (ICP10 PK) blocks apoptosis in hippocampal neurons, involving activation of the MEK/MAPK survival pathway. J Virol. 2002; 76: 1435–49. pmid:11773417
  9. 9. Smith CC, Nelson J, Aurelian L, Gober M, Goswami BB. Ras-GAP binding and phosphorylation by herpes simplex virus type 2 RR1 PK (ICP10) and activation of the Ras/MEK/MAPK mitogenic pathway are required for timely onset of virus growth. J Virol. 2000; 74: 10417–29. pmid:11044086
  10. 10. Faith SA, Sweet TJ, Bailey E, Booth T, Docherty JJ. Resveratrol suppresses nuclear factor-kappa B in Herpes simplex virus infected cells. Antiviral Res. 2006; 72: 242–51. pmid:16876885
  11. 11. Kutluay SB, Doroghazi J, Roemer ME, Triezenberg SJ. Curcumin inhibits Herpes simplex virus immediate-early gene expression by a mechanism independent of p300/CBP histone acetyltransferase activity. Virology. 2008; 373: 239–47. pmid:18191976
  12. 12. Dai X, Sayama K, Yamasaki K, Tohyama M, Shirakata Y, Hanakawa Y, et al. SOCS1-negative feedback of STAT1 activation is a key pathway in the dsRNA induced innate immune response of human keratinocytes. J Invest Dermatol. 2006; 126: 1574–79. pmid:16628196
  13. 13. Mogensen TH, Paludan SR. Molecular pathways in virus-induced cytokine production. Microbiol Mol Biol Rev. 2001; 65: 131–50. pmid:11238989
  14. 14. Ghosh S, Samanta A, Mandal NB, Banerjee S, Chattopadhyay D. Evaluation of wound healing activity of methanolic extract of Pedilanthus tithymaloides (L.) Poit leaf and its isolated active constituents in topical formulation. J Ethnopharmacol. 2012; 142(3): 714–22. pmid:22683906
  15. 15. Ghosh S, Chattopadhyay D, Mandal A, Kaity S, Samanta A. Bioactivity guided isolation of anti-inflammatory, analgesic and antipyretic constituents from the leaves of Pedilanthus tithymaloides (L.) J Med Chem Res. 2013; 22: 4347–59.
  16. 16. Bunyapraphatsara N, Chokchaichareonporn A. Medicinal Plants Indigenous to Thailand. Prachachon, Bangkok, 2000; pp. 691.
  17. 17. Kumar GP, Chaturvedi A. Ethnobotanical observations of Euphorbiaceae species from Vidarbha region, Maharashtra, India. Ethnobotanical Leaflets. 2010; 14: 674–80.
  18. 18. Lee JK, Kim SY, Kim YS, Lee W-H, Hwang DH, Lee JY. Suppression of the TRIF-dependent signaling pathway of Toll-like receptors by luteolin. Biochem Pharmacol. 2009; 77: 1391–400. pmid:19426678
  19. 19. Xu L, Su W, Jin J, Chen J, Li X, Zhang X, et al. Identification of Luteolin as Enterovirus 71 and Coxsackievirus A16 Inhibitors through Reporter Viruses and Cell Viability-Based Screening. Viruses. 2014; 6(7): 2778–95. pmid:25036464
  20. 20. Vrijsen R, Everaert L, Boey A. Antiviral Activity of Flavones and Potentiation by Ascorbate. J Gen Virol. 1988; 69: 1749–51. pmid:2839607
  21. 21. Liu AL, Liu B, Qin HL, Lee SM, Wang YT, Du GH. Anti-influenza virus activities of flavonoids from the medicinal plant Elsholtzia rugulosa. Planta Med. 2008; 74(8): 847–51. pmid:18553272
  22. 22. Mehla R, Bivalkar-Mehla S, Chauhan A. A Flavonoid, Luteolin, Cripples HIV-1 by Abrogation of Tat Function. PLoS One. 2011; 6(11): e27915. pmid:22140483
  23. 23. Behbahani M, Zadeh MS, Mohabatkar H. Evaluation of antiherpetic activity of crude extract and fractions of Avicenna marina, in vitro. Antiviral Research. 2013; 97: 376–80. pmid:23333436
  24. 24. Chen X, Wangb Z, Yang Z, Wang J, Xu Y, Tan R, et al. Houttuynia cordata blocks HSV infection through inhibition of NF-κB activation. Antiviral Res. 2011; 92: 341–5. pmid:21951655
  25. 25. Krylova NV, Popov AM, Leonova GN, Artiukov AA, Maĭstrovskaia OS. Comparative study of antiviral activity of luteolin and 7,3'-disulfate luteolin. Antibiot Khimioter. 2011; 56(11–12): 7–10. pmid:22856150
  26. 26. Mukherjee H, Ojha D, Bag P, Chandel HS, Chawla Sarkar M, Chatterjee TH, at al. Antiherpes activities of a Triterpene acid of Achyranthes aspera: an Indian ethnomedicine. Microbiol Res. 2013; 168: 238–44. pmid:23218996
  27. 27. Bag P, Chattopadhyay D, Mukherjee H, Ojha D, Mandal N, Chawla Sarkar M, et al. Anti-herpes virus activities of bioactive fraction and isolated pure constituent of Mallotus peltatus: an ethnomedicine from Andaman Islands. Virology J. 2012; 9:98.
  28. 28. Bag P, Ojha D, Mukherjee H, Halder UC, Mondal S, Nandi S, et al. An indole alkaloid from a Tribal folklore inhibits immediate early event in HSV-2 infected cells with therapeutic efficacy in vaginally infected mice. PloS One. 2013; 8(10): e77937. pmid:24167591
  29. 29. Bag P, Ojha D, Mukherjee H, Halder UC, Mondal S, Biswas A, et al. A Dihydro-pyrido-indole potently inhibits HSV-1 infection by interfering the viral immediate early transcriptional events. Antiviral Res. 2014; 105:126–34. pmid:24576908
  30. 30. Wang QY, Zhou C, Johnson KE, Colgrove RC, Coen DM. Herpes viral latency-associated transcript gene promotes assembly of heterochromatin on viral lytic-gene promoters in latent infection. Proc Natl Acad Sci USA. 2005; 102(44): 16055–9. pmid:16247011
  31. 31. Bhattacharjee S, Gupta G, Bhattacharya P, Mukherjee A, Mujumdar SB, Pal A, et al. Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity. J Antimicrob Chemother. 2009; 63(2): 317–24. pmid:19036753
  32. 32. Hirobe C, Qiao ZS, Takeya K, Itokawa H. Cytotoxic flavonoids from Vitex agnus-castus. Phytochem. 1997; 46: 521–4.
  33. 33. Chenoweth MJ, Mian MF, Barra NG, Alain T, Sonenberg N, Bramson J, et al. IL-15 can signal via IL-15Rα, JNK, and NF-κB to drive RANTES production by myeloid cells. J Immunol. 2012; 188(9): 4149–57. pmid:22447977
  34. 34. Chattopadhyay D, Khan MTH. Ethnomedicines and ethnomedicinal phytophores against Herpesviruses. Biotech Annual Rev. 2008; 14: 297–348.
  35. 35. Khan MT, Ather A, Thompson KD, Gambari R. Extracts and molecules from medicinal plants against Herpes simplex viruses. Antiviral Res. 2005; 67: 107–19. pmid:16040137
  36. 36. Roizman B, Knipe DM, Whitley RJ. Herpes simplex viruses. In: Knipe DM, et al. editors. Fields virology, vol. 2, 5th ed. Philadelphia, PA: Lippincott, Williams & Wilkins, 2007; pp. 2501–601.
  37. 37. Donald MC, Shaffer PA. Antiherpes virus drugs: a promising spectrum of new drugs and drug targets. Nature Rev Drug Discovery. 2003; 2: 278–88.
  38. 38. Zachos G, Clements B, Conner J. Herpes simplex virus type 1 infection stimulates p38/c-Jun N-terminal mitogen-activated protein kinase pathways and activates transcription factor AP-1. J Biol Chem. 1999; 274: 5097–103. pmid:9988758
  39. 39. McLean TI, Bachenheimer SL. Activation of cJUN N-terminal kinase by Herpes simplex virus type 1 enhances viral replication. J Virol. 1999; 73: 8415–26. pmid:10482593
  40. 40. Amici C, Belardo G, Rossi A, Santoro MG. Activation of IkB kinase by Herpes simplex virus type 1. J Biol Chem. 2001; 276: 28759–66. pmid:11387335
  41. 41. Amici C, Rossi A, Costanzo A, Ciafrè S, Marinari B, Balsamo M, et al. Herpes simplex virus disrupts NF-kB regulation by blocking its recruitment on the IκB-α promoter and directs the factor on viral genes. J Biol Chem. 2006; 281: 7110–7. pmid:16407234
  42. 42. Song S, Qiu M, Chu Y, Chen D, Wang X, Su A, et al. Down regulation of cellular c-Jun N-terminal protein kinase and NF-κB activation by berberine may result in inhibition of herpes simplex virus replication. Antimicrob Agents Chemother. 2014; 58(9): 5068–78. pmid:24913175
  43. 43. Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol. 2005; 70: 700–13. pmid:16023083
  44. 44. Ludwig S. Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy. J Antimicrobial Chemother. 2009; 64(1): 1–4.
  45. 45. Baba M. Recent status of HIV-1 gene expression inhibitors. Antiviral Res. 2006; 71: 301–6. pmid:16488488
  46. 46. Swiecki M, Wang Y, Gilfillan S, Colonna M. Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections. PLoS Pathog. 2013; 9(10): e1003728. pmid:24204273
  47. 47. Dai X, Sayama K, Tohyama M, Shirakata Y, Yang L, Hirakawa S, et al. The NF-κB, p38 MAPK and STAT1 pathways differentially regulate the dsRNA-mediated innate immune responses of epidermal keratinocytes. International Immunol. 2008; 20(7): 901–9.